摘要
目的总结维吾尔族药物治疗糖脂代谢性疾病的研究进展。方法以《中华本草·维吾尔药卷》《中国医学百科全书·维医学》记载的品种目录为依据,检索CNKI、PubMed、维普数据库、万方数据库等,梳理、总结、归纳治疗糖脂代谢性疾病的常用维吾尔族单味药、复方、中成药的研究进展。结果治疗糖尿病的单味药有阿魏、胡芦巴、黑桑、鹰嘴豆和石榴等,复方有孜亚比提片(散)和复方卡巴比其尼洗液,中成药有消渴健脾胶囊;治疗高脂血症的单味药有水蛭、胡椒、大蒜和马齿苋等,复方有买提布合艾菲提蒙方和艾菲提蒙汤;治疗动脉粥样硬化的单味药有西红花、唇香草、罗勒和香青兰等,复方有艾菲提蒙汤和养心达瓦依米西克蜜膏,中成药有爱维心口服液。结论维吾尔族药物治疗糖脂代谢性疾病具有丰富经验,可为现代医药研究和开发防治糖脂代谢性疾病的新药提供启示和参考,值得对其进行进一步的挖掘。
Objective To summarize the research progress of drug treatment of glucolipid metabolic diseases in Uyghur.Methods Based on the variety catalogs recorded in Chinese Materia Medica·Uyghur Medicine Volume and Encyclopedia of Chinese Medicine·Uyghur Medicine,this paper searched CNKI,PubMed,CQVIP database,Wanfang database,etc.,and sorted out,summarized the research progress of commonly used Uyghur single medicine,compounded medicines and Chinese patent medicines for the treatment of glucolipid metabolic diseases.Results In Uyghur medicines,single medicines for diabetes include Ferula,Trigonella foenum-graecum L.,Morus nigra,Chickpea and Pomegranate,etc.;Compounded medicines include Ziyabiti Tablets(powder)and Compounded Kababiqini Lotion,and Chinese patent medicines include Xiaoke Jianpi Capsules.The single medicine treatment for hyperlipidemia include leech,pepper,garlic and Portulaca oleracea,etc.;Compounded medicines include decoction of Maitibuhe aifeitimeng and Aifeitimeng.Single medicine for atherosclerosis include Crocus sativus L.,Ziziphora clinopodioides Lam.,Ocimum basilicum L.and Dracocephalum moldavica,etc..The compounded drugs include Aifeitimeng Decoction and Yangxin Dawayimixike Paste,and the Chinese patent medicines include Aiweixin Oral Liquid.Conclusion The Uyghur people have rich experience in drug treatment of glycolipid metabolic diseases,which can provide inspiration and reference for modern medical research and new drug development to prevent and treat glycolipid metabolic diseases,and is worthy of further exploration.
作者
陶洁
周修腾
罗朵生
TAO Jie;ZHOU Xiuteng;LUO Duosheng(Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine,Guangdong Pharmaceutical University,Guangzhou 510000,China;Guangdong Key Laboratory of Metabolic Disease Prevention and Treatment of Traditional Chinese Medicine,Guangzhou 510000,China;State Key Laboratory Breeding Base of Genuine Medicinal Materials,National Resource Center for Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China)
出处
《西北药学杂志》
CAS
2024年第4期227-234,共8页
Northwest Pharmaceutical Journal
基金
中国中医科学院科技创新工程项目(编号:CI2021B014)。
关键词
维吾尔族药
糖尿病
高脂血症
动脉粥样硬化
Uyghur medicine
diabetes mellitus
hyperlipidemia
atherosclerosis